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The last decade has seen considerable advances in our understanding of intrinsic 
developmental mechanisms associated with gametogenesis and embryogenesis, 
and accompanying applications in the fields of reproductive medicine, 
embryonic stem cell biology and nuclear reprogramming. However, a new focus 
has recently emerged concerning the homeostatic regulation of embryonic cells, 
how this is set and how it may influence the longitudinal progression and 
optimisation of the developmental programme, and indeed the phenotype of the 
offspring. Attention has been drawn to the preimplantation stage of development 
as a sensitive ‘window’ when in vitro and in vivo manipulations, such as culture 
conditions or maternal diet, may have critical consequences. In this article, we 
review how changes in environmental conditions, mediated via a range of 
epigenetic, cellular and metabolic mechanisms in the preimplantation embryo, 
may alter the pattern of cell division, gene expression, morphology and potential. 
We consider how fetal and postnatal phenotype may become susceptible to the 
plasticity of the preimplantation embryo, and the risks for adult health and 
physiology. 
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INTRODUCTION 
Mammalian preimplantation development is subject to both genetic determinants and 
environmental factors. During this time the early embryo undergoes cleavage and 
blastocyst morphogenesis and the first two cell lineages segregate, the outer 
trophectoderm (TE) which will form the chorio-allantoic placenta later in pregnancy, 
and the inner cell mass (ICM) from which will derive the entire fetus. Homeostatic 
responses by the embryo to environmental cues, both in vivo and in vitro, have been 
shown to affect the long-term potential for health or predispose to adult disease (1-4; 
Fig.1). Several studies using rodent and domestic animal models have demonstrated 
that environmental conditions experienced during early development shape critical 
aspects of future growth, metabolism, gene expression and physiology. Thus, changes 
in periconceptual maternal diet can impact upon ovulatory fitness and blastocyst 
proliferation, leading to altered fetal metabolic and cardiovascular development and 
adult hypertension (5-11). Similarly, in vitro culture of embryos can associate with 
changes in fetal growth (4, 12-15), gene expression and regulation (15-17), postnatal 
behaviour (18, 19), and raised systolic blood pressure (20). These longitudinal 
associations are pertinent for preventative healthcare concerning nutrition during 
pregnancy as well as the safety of assisted reproduction technologies (ART) in the 
treatment of infertility, and underlie the need for elucidation of causal mechanisms 
and protective strategies.  
 
EMBRYO DEVELOPMENT AND ENVIRONMENTAL SENSITIVITY IN 
VIVO 
 
To evaluate the causes of environment-induced changes in embryo developmental 
potential, we first consider the nature of maternal-embryonic interactions within the 
relatively undisturbed reproductive tract. This may shed light on how the embryo may 
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respond to sub-optimal conditions and the consequences of this response. The 
spectrum of maternal-embryonic signalling is broad and a range of metabolites, 
growth factors, macromolecules and developmental cues are involved in regulating 
embryo metabolism and growth (21, 23-26). The metabolic requirements of the 
embryo change as it travels from the oviduct towards the uterus; during early 
cleavage, the embryo predominantly metabolises pyruvate, but switches to glucose 
during compaction and throughout blastocyst development (27-30). Coupled with 
this, non-essential amino acids and glutamine increase the rate of cleavage in mouse 
(31, 32), human (33), bovine (34) and sheep (22) pre-compaction embryos, whilst 
post-compaction, essential amino acids are more influential (22, 31, 32). In response 
to these changing requirements, the oviduct is relatively rich in pyruvate and low in 
glucose and provides the embryo with the necessary non-essential amino acids. 
Conversely, the uterine environment is richer in glucose and essential amino acids 
(35, 36). Recent proteomic research indicates that the interaction between the 
reproductive tract and gametes and embryos is both dynamic and critical for 
reproductive progression (37, 38). Interestingly, recent studies have shown the 
metabolic activity of the early human embryo may be indicative of its potential, in 
that lower rates of amino acid exchange, perhaps symptomatic of low metabolic 
stress, correlate with improved viability after transfer (39-41).  
 
Maternal diabetes and hyperglycaemia 
The link between embryo in vivo metabolic environment and longer-term health is 
evident in women with maternal diabetes where the hyperglycaemic environment 
increases the risk of spontaneous abortion and fetal abnormalities (42, 43). 
Blastocysts recovered from diabetic mice and rats have higher rates of chromatin 
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degradation, nuclear fragmentation and apoptosis of ICM cells than embryos from 
controls (44, 45). Similarly, the culture of normal mouse or rat blastocysts in high 
glucose concentrations increases the expression of pro-apoptotic markers (45). One 
mechanism through which elevated glucose may induce blastocyst apoptosis is via the 
down regulation of glucose transporters (GLUTs), resulting in decreased intracellular 
glucose concentration and increased apoptosis (46-48). Blastocysts from Glut1 
(Slc2a1) knock-down mice show increased apoptosis and reduced glucose transport 
(49), indicating appropriate intracellular glucose availability is critical for embryo 
survival (50). Moreover, a high embryonic glucose environment also impacts 
negatively upon fetal development with increased frequency of resorptions and 
malformations and reduced fetal growth (46, 48, 49). Decreased insulin/IGF-1 
signalling via the PI3-K and Akt pathway may be a central mediator of reduced 
embryo potential (50). Thus, activation of the PI3-K pathway by platelet activating 
factor has been shown to be essential for preimplantation embryo development and 
survival (51), whilst inhibition of the PI-3K/Atk pathway in murine blastocysts results 
in reduced GLUT1 expression and glucose uptake, impaired blastocyst development 
and increased apoptosis and nuclear fragmentation (50-52).  
 
Mitochondrial function and blastocyst potential 
Central to the relationship between glucose metabolism and apoptosis is the 
mitochondrion. Whilst mitochondrial ATP production is essential for oocyte 
maturation, Ca2+ homeostasis and post-fertilisation development (53-55), 
mitochondrial dysfunction and subsequent changes in calcium signalling can result in 
apoptosis in the oocyte and early embryo (53).  
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There also exists a secondary mechanism through which mitochondria can 
influence aspects of post-fertilisation development. In the maturing oocyte, 
mitochondria undergo rapid rates of division followed by replication arrest during 
cleavage (56). Suboptimal environmental conditions can increase reactive oxygen 
species (ROS) levels causing increased mitochondrial DNA (mtDNA) mutations (57). 
Thus, any mtDNA mutations incurred during oocyte maturation will be maintained 
during early embryonic development. Alongside this, heterogeneity in the distribution 
of mitochondria in the oocyte could result in asynchronous mitochondrial loads in the 
resultant blastomeres, altering future developmental and metabolic profile (58, 59). 
 
Maternal diet 
An altered uterine environment leading to adverse embryo responses can also derive 
from changes to maternal diet. Maternal low protein diet (LPD) given to rat dams 
exclusively during the preimplantation period (0-4.25 days) resulted in mild transient 
maternal hyperglycaemia, reduced blastocyst cell numbers, gender-specific 
programming of imprinted gene expression and altered postnatal growth and 
hypertension (5, 6). This treatment also increased the expression of the 11β-
hydroxysteroid dehydrogenase type 1 (Hsd11b1) gene responsible for activating 
glucocorticoid in fetal liver, together with increased expression of 
phosphoenolpyruvate carboxykinase (Pepck, Pck1) gene, encoding the rate-limiting 
enzyme for gluconeogenesis (7). Studies in sheep have further demonstrated that 
either periconceptional maternal undernutrition or a high protein diet can lead to 
reduced developmental viability, abnormal fetal and postnatal growth and changes in 
fetal endocrinology (8, 9, 60, 61). In the sheep, periconceptional undernutrition may 
act through enhanced stimulation of the HPA axis leading to increased fetal blood 
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pressure in twins and postnatal cardiovascular dysfunction in singletons (8-11, 62, 63) 
as well as changes in the fetal IGF axis (64, 65). 
 
Domestic animal studies have also shown follicular growth and oocyte quality 
to be affected by a range of dietary manipulations (66-69). Dietary energy levels 
influence both morphology and developmental competence of bovine oocytes (70) 
although increased protein intake may also elevate ammonia content in follicular fluid 
resulting in reduced blastocyst development (71-74). High levels of maternal nitrogen 
metabolism prior to embryo collection and in vitro culture has been shown to increase 
fetal development and alter gene expression (73).  
 
EMBRYONIC DEVELOPMENT AND ENVIRONMENTAL SENSITIVITY IN 
VITRO 
 
Despite advances in the composition and properties of embryo culture media for ART 
and domestic animal biotechnology purposes, in vitro culture generally remains 
inferior to the in vivo environment for the rate of embryo development (1, 4, 12, 20, 
75). An early, and perhaps the most dramatic, example of embryo culture having an 
adverse effect on the developmental programme is the phenomenon of ‘large 
offspring syndrome’ (LOS). LOS was observed after culture of sheep and cattle 
embryos in the presence of serum resulting in increased weight at birth, increased 
muscle mass, cerebellar dysplasia, skeletal and facial malformations, changes in the 
normal size and weight of internal organs and sudden perinatal death (76-80). A LOS 
phenotype has also been observed following the process of cloning by nuclear 
transfer, the co-culture of embryos on granulosa cells, the transfer of embryos to an 
asynchronous uterine environment and the exposure of embryos to a high 
progesterone uterine environment (76-79, 81). It is of interest to note that sheep 
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embryos cultured in the presence of serum display increased glycolysis when 
compared to embryos derived in vivo or cultured in the absence of serum (22). These 
changes may arise from increased mitochondrial degeneration observed for embryos 
cultured in serum compared with serum-free conditions (82, 83). As outlined above, 
mitochondrial function and morphology in response to environmental perturbations 
may be a useful indicator of embryo developmental potential. Serum-free culture 
conditions have been successfully employed for the human (84), mouse (32) and 
ruminant species (85) to protect embryo proliferation and fetal growth. Recently, it 
has been shown that the pre-compact ovine embryo is more sensitive to serum in 
culture than the post-compact embryo, although culture in the absence of serum was 
most beneficial for maintaining normal fetal growth (86). 
 
Other long-term effects mediated by embryo culture indicate vulnerability to a 
wide range of postnatal conditions. In vitro embryo culture and transfer of mouse 
preimplantation embryos has been shown to adversely alter postnatal behaviour and 
memory and growth (18, 19) but not longevity (87). Also in the mouse, in vitro 
culture for either a prolonged (2-cell to blastocyst) or brief period (1-2 hours as 
blastocysts) prior to transfer resulted in elevation of adult blood pressure and activity 
of the cardiovascular regulator, serum angiotensin converting enzyme (ACE) and the 
gluconeogenesis controller, hepatic phosphoenolpyruvate carboxykinase (PEPCK) in 
female offspring (20).  
 
Short-term effects of embryo culture alter the global pattern of gene 
expression within blastocysts, indicating the sensitivity of several gene pathways. 
(88). In vitro derived bovine blastocysts exposed to serum display altered expression 
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profiles of metabolic and growth regulator genes including BAX, leukemia inhibitory 
factor (LIF), LIF-Rβ, basic fibroblast growth factor (bFGF), insulin-like growth 
factor-I receptor (IGF1R) and superoxide dismutase (SOD) compared to embryos 
cultured in serum-free medium or developing in vivo (89-91). In vitro produced 
bovine embryos also alter their expression profiles of GLUT1 in response to changes 
in oxygen concentrations (92) while in the mouse, expression of Glut1 (Slc2a1), Glut3 
(Slc2a3) and Vegf (Vegfa) are all increased by 2% versus 20% oxygen (93). These 
changes in metabolic regulators indicate conservation in mechanisms with in vivo 
environmental sensitivity, particularly diabetes and hyperglycaemia. 
 
Despite this apparent negative effect of in vitro culture, a range of 
modifications to the culture environment have been shown to significantly improve 
embryo development such as the addition of amino acids and/or growth factors, 
reduction in the level of ammonium ions, and culture in a low O2 atmosphere (4). It 
has been proposed that the composition of culture medium is of more influence upon 
developmental outcome than the procedure of in vitro culture itself (4). The addition 
of physiological concentrations of insulin and IGF-1 increase the number of cells 
within mouse, bovine and human preimplantation embryos (94-99), predominantly 
via the stimulation of ICM proliferation (94, 95, 98-102) and the inhibition of 
apoptosis (96-99). Insulin and IGF-1 also stimulate embryo metabolism, increasing 
protein endocytosis whilst reducing the catabolism of the incorporated protein (103, 
104). Mouse embryos cultured in the presence of insulin and albumin result in 
increased fetal weight after transfer (105). More recently, the addition of granulocyte-
macrophage colony-stimulating factor (GM-CSF) to the culture medium has been 
shown to alleviate some of the detrimental influences of mouse embryo culture on 
 10 
fetal viability and growth, predominantly mediated through the alteration of placental 
morphogenesis (106). Leptin has also been shown to enhance in vitro mouse embryo 
development and stimulate trophectoderm proliferation (107), whilst ghrelin, know to 
modulate feeding behaviour and energy metabolism, negatively influences mouse 
preimplantation embryo development in vitro (108).  
 
 The findings that in vitro culture conditions can have dramatic consequences 
on postnatal health of mice and domestic livestock pose questions as to the long term 
health of ART children. Despite the increased ability to culture and manipulate 
gametes and embryos, the pregnancy rate from ART remains low with only 
approximately 23% of women undergoing treatment becoming pregnant (109). 
Incidences of multiple pregnancies are increased in patients receiving ART and as a 
consequence, children conceived through ART are more likely to be born premature 
and with a low birth weight (<2500g) (110, 111). A recent comprehensive review of 
the data currently available on postnatal development of children conceived via ART 
concluded that the combination of the low birth weight and the inherent defects in 
parental gametogenesis were the most likely cause of any altered postnatal 
development, and that children born after ART were healthy and developmentally 
similar to children naturally conceived (110). However, as the oldest person born 
from ART is still under the age of 30, it is difficult to gauge how long-term health and 
development may be affected. Indeed, the data from numerous animal studies has 
shown that the physiological consequences arising from altered embryo development 
may not manifest themselves till adulthood (20, 112). It will therefore be of particular 
interest to follow the long term health and development of children conceived via 
ART. As well as this, we feel that certain aspects of postnatal physiology are being 
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under-investigated. Data from our laboratory has demonstrated consistently that 
cardiovascular function is perturbed in mice and rats derived from embryos which 
have experienced altered rates of preimplantation embryo development (5, 20, 113). 
However, in studies examining the postnatal development of ART children, the main 
emphasis has been upon neurological development, rates of surgical interventions and 
growth rather than cardiovascular health (112).  
 
THE SEARCH FOR MECHANISMS 
From the evidence presented above, environmentally-induced changes in embryos 
leading to altered developmental potential associate with a broad range of outcomes 
affecting gene expression, cell proliferation, embryo/fetal growth, metabolic and 
cardiovascular physiology, and neurological criteria, especially behaviour. This 
breadth is indicative of multiple and interacting mechanisms at molecular, cellular and 
systems levels (1). An enduring requirement is the cellular heritability and longevity 
of the response activated at the onset of development yet persisting into adult life. The 
fundamental mediator of cellular heritability in this context appears to reside in the 
epigenetic status of embryos and how this may be vulnerable to environmental 
conditions. The term epigenetics in the modern sense refers to heritable changes in 
gene expression without alterations of DNA sequence, mediated by altered 
methylation of the DNA and remodeling of chromatin (114). DNA modifications in 
mammals occur as cytosine methylation at CpG dinucleotides. While most CpGs are 
methylated throughout the genome, CpGs in gene regulatory elements can be 
differentially methylated as an epigenetic modification. In addition, the core histones 
forming the nucleosome can be subject to a vast number of posttranslational 
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modifications such as methylation, acetylation, ubiquitylation, phosphorylation, 
sumoylation and deimination of specific amino acid residues, affecting accessibility 
and transcriptional activity of chromatin (recently reviewed in (115). DNA 
methylation marks as well as histone modification marks are thought to interact and 
confer heritability while allowing for plasticity and reversibility if necessary. One of 
the best known examples for an epigenetic mechanism is the regulation of mammalian 
imprinted genes with roles in growth regulation during pregnancy and beyond. These 
genes exhibit parent-of-origin-specific monoallelic expression, such that growth-
promoting genes  are expressed exclusively from the paternal allele, whereas for 
growth-inhibiting genes only the maternal allele is active.    
Together with gametogenesis, preimplantation development is one of two 
periods of dynamic epigenetic reprogramming during the mammalian life cycle, as 
recently reviewed by Morgan et al. (116). This period starts with fertilisation where 
the paternal chromatin sees the sperm protamines replaced by acetylated histones 
(117, 118), followed by active DNA demethylation, which however spares paternally 
methylated imprinted loci (119), intracisternal A particle (IAP) transposons (120) and 
heterochromatic centromere regions (118, 121). The new histones recruited to the 
male pronuclear DNA carry a high level of acetylation marks compared to the 
maternal chromatin, whereas other histone modifications are present in the female 
pronucleus early on, but are only gradually acquired during male pronuclear 
development. Following syngamy, through the early cleavage divisions, there is a loss 
of genome methylation, apparently by a passive mechanism. However this excludes 
imprinted alleles which retain their status. In the ICM this is followed by extensive 
remethylation from the morula stage onward, likely mediated by the de novo DNA 
methylase Dnmt3b which is detectable in the ICM but not in the trophectoderm (122). 
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In marked contrast, the placental DNA remains close to the undermethylated ground 
state created by the combination of active and passive demethylation. We will next 
consider the evidence why epigenetics may be at the heart of environment-induced 
embryo programming. 
 
ROLE FOR EPIGENETICS  IN EMBRYO LINEAGE ALLOCATION 
The first lineage allocations in mouse take place early in development before 
implantation and are under genetic control, as reviewed elsewhere (123). It is thought 
that the first blastomeres represent totipotent precursor cells. These will undergo 
lineage decisions based on antagonisms between transcription factor genes. In the first 
decision, morula ICM (inner cell mass) cells are characterised by continued Oct4 
expression, whereas the outer cells express Cdx2 and become trophectoderm. A 
second lineage separation takes place in the blastocyst ICM between epiblast cells 
expressing Nanog, and the cells facing the blastocoel which express Gata6 and 
become primitive endoderm. This might be taken as evidence that perturbations of 
gene expression patterns during the preimplantation period, possibly acting through 
epigenetic mechanisms, could lead to changes in lineage allocation and altered 
developmental trajectories for the embryo and extraembryonic tissues. A recent report 
reinforced this notion and focused attention to the very first days of mammalian 
development (124). As early as the four cell stage, the authors demonstrated 
differential histone modification between blastomeres, which was predictive of their 
respective lineage contributions. Overexpression of the implicated histone methylase 
in individual blastomeres induced expression of specific transcription factors 
concomitant with certain lineage allocations. These data implicate the precompaction 
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stage of mammalian development in lineage allocation by epigenetic mechanisms, 
and thus as a window of development potentially sensitive to environmental cues or 
noxious influences. 
SUBOPTIMAL IN VITRO CULTURE INDUCES EPIGENETIC CHANGES 
AT IMPRINTED GENES.  
There is growing evidence that embryo culture conditions induce changes in 
epigenetic status. As outlined above, LOS in sheep and cattle has been linked to fetal 
calf serum exposure during embryo culture. The timing of this exposure and the 
similarities between LOS and human imprinting disorders (such as Beckwith-
Wiedemann syndrome) implicated epigenetic modifications of genes with functions in 
growth and development (125). Indeed, LOS sheep fetuses after embryo culture had 
reduced DNA methylation and expression of the normally active maternal allele of the 
IGF2 receptor gene (126). This is consistent with the overgrowth of Igf2r knockout 
mice (127, 128) and repressed Igf2r expression upon loss of maternal methylation in 
Dnmt1 knockout mice (129). When different time windows were tested for the impact 
of serum exposure on later fetal growth, the highest effect of culture with serum was 
seen before embryo compaction, implicating the precompaction phase of development 
as particularly sensitive to changes in embryo environment (86). Imprinted gene loci 
normally escape the genome-wide demethylation during early cleavage divisions, 
retaining their germline imprints, but it is not clear what DNA/chromatin marks are 
required for this or which Dnmt sustains methylation of these loci. Whatever the 
mechanism by which imprinted loci retain their correct status, it appears to be 
disturbed by serum exposure during the first cleavage divisions in ruminants.  
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Several studies were conducted to determine the effects of serum on rodent embryos. 
Preimplantation exposure to FCS caused mouse fetuses derived by uterine transfer to 
express decreased levels of the imprinted Igf2 and H19 gene, concomitant with 
increased DNA methylation at the imprinting control region (130). There were also 
effects on imprinted growth factor binding genes: Grb10 expression was increased, 
while Grb7 expression was lowered. In another mouse study (19), embryos harvested 
from superovulated females were cultured from the one cell stage in KSOM 
containing either 10% serum or 1 g/l BSA (control). The serum-cultured group 
showed abnormalities in imprinted gene expression by the blastocyst stage: 
maternally expressed Grb10/Meg1 and paternally expressed Igf2 and Mest/Peg1 
mRNA were all reduced with no significant difference in H19. Notably, and similar to 
the sheep LOS syndrome data, the period of exposure to serum included cleavage 
divisions of the early blastomeres, and when such blastocysts were allowed to develop 
following uterine transfer, a pattern of long-term abnormalities was evident including 
increased body weight, changed organ allometry, and anxiety-, memory- and 
locomotor-related abnormalities (19).  
Several studies have found altered imprinted gene expression in response to embryo 
culture parameters other than serum exposure. Mouse blastocysts cultured in 
Whitten's medium showed aberrant H19 expression from the normally silent paternal 
allele concomitant with a loss of DNA methylation at the upstream imprinting control 
region, whereas H19 expression and methylation were more in-vivo-like upon culture 
in KSOM with amino acids (131). Further, this loss of H19 imprinting induced by 
culture in Whitten's medium was shown to persist in the fetus, whereas placenta 
expression from the normally silent allele was demonstrated for a number of genes, 
namely H19, Ascl2, Snrpn, Peg3, Xist (132).  
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In a recent study to investigate the effects of embryo culture conditions frequently 
used in human IVF, IVF-derived Mus musculus/Mus spretus F1 hybrid embryos, 
when cultured in human tubal fluid, exhibited abnormal H19 imprinting concomitant 
with abormal DNA methylation at a CTCF binding site in the imprinting control 
region, indicative of the acquisition of a paternal methylation pattern by the normally 
unmethylated maternal allele (133). This was accompanied by altered histone 
methylation marks on both alleles at the same CTCF binding site, evidence for a link 
of abnormal DNA methylation and histone methylation in the aberrant imprinting 
pattern on the maternal allele caused by the culture conditions. Another example of 
potentially altered epigenetic status of embryos in response to culture conditions 
concerns changes in H19 gene expression in blastocysts and longer term fetal 
abnormalities associated with ammonium build up from amino acid break down (74, 
134). 
ART AND IMPRINTING DISORDERS 
As recently reviewed elsewhere (135), there are a number of studies pertinent to the 
relationship between ART procedures and the incidence of imprinting disorders. 
There have been reports on individual ICSI-conceived children with Angelmann 
Syndrome (AS) where an imprinting defect was demonstrated (136, 137). Likewise, 
there have been reports of IVF and ICSI children with Beckwith-Wiedemann 
Syndrome (BWS), albeit without analysis of the underlying defect (reviewed in (138). 
A number of patient-based studies of the prevalence of BWS, as well as a large case 
control study have found a three to nine fold increase in ART children (139-142). It 
should be noted that the underlying defect in the AS as well as BWS cases is 
hypomethylation of the maternal alleles' imprinting control region. Thus, even though 
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the risk of an imprinting disorder after ART is very low and not cause for alarm, its 
increase compared to conventionally conceived children is compatible with an 
adverse effect of preimplantation manipulation and culture on proper establishment of 
epigenetic marks.      
 
EVIDENCE FOR EPIGENETIC EFFECTS OF PROTEIN RESTRICTED 
DIET 
Persistent and gene-specific epigenetic changes in response to maternal diet were 
found in a study on rats (143). When female pregnant rats were fed a protein restricted 
diet throughout pregnancy (including preimplantation stages) this caused reduced 
DNA methylation of the peroxisomal proliferator activated receptor (PPAR) alpha 
and Glucocorticoid receptor (GR) genes and increased their expression in the 
offspring post-weaning; these effects could be abolished by folic acid 
supplementation of the protein-restricted diet. Further, GR hepatic promoter showed 
changed histone marks consistent with transcriptional activation in addition to DNA 
hypomethylation. Intriguingly, DNA methyltransferase 1 (Dnmt1) was implicated in 
these epigenetic changes because its expression was significantly reduced and its 
variation could to a large degree explain variation in GR promoter methylation (144). 
As the maternal protein restriction used extended throughout the entire pregnancy, it 
is tempting to speculate whether protein restriction during the preimplantation period 
would be sufficient to induce permanent alterations to Dnmt expression. 
In this context, maternal low protein diet treatment to rats exclusively during 
preimplantation development leading to postnatal phenotypic changes (5) may include 
an epigenetic mechanism. Thus, this treatment resulted in male blastocysts showing 
reduced H19 expression levels, which was mirrored by reduced H19 and Igf2 
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expression in male fetal livers (6). Importantly, extension of the maternal protein 
restriction beyond the preimplantation stage abolished the downregulation of H19 and 
Igf2 in fetal liver, indicating that the blastocyst's early response is an appropriate one 
when protein restriction continues.  
 In order to understand the mechanisms of preimplantation maladaptive programming 
during the preimplantation window of sensitivity, it is imperative to investigate its 
molecular basis, for instance at the level of signalling, gene expression and altered 
epigenetic modifications in the embryo. Furthermore, we must unravel how the 
pertinent subsequent phenotypic effects become manifest in the fetus itself and its 
supply systems (including cross talk between fetus, yolk sac and placenta) from a 
physiological, endocrine and metabolic perspective. 
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Figure captions 
 
 
Figure 1. Diagram representing potential interactions of the preimplantation embryo     
with the environment, either in vivo or in vitro, the short term responses, and the long  
term consequences induced. 
 
